针对MEP通路基因DXS,IspD和IspF的有针对性的抑制,以探索菌根菌代谢和生存
Nidhi Rani1, Avadhesha Surolia2
1Molecular Biophysics Unit, Indian Institute of Science, Bangalore 560012, India.
International journal of biological macromolecules
|June 1, 2024
概括
降低Mycobacterium smegmatis中重要的MEP通路基因的下调,表现出杀菌作用,并增加对结核病药物的敏感性. 这突出了MEP通路酶作为潜在的抗结核药物点.
科学领域:
- 微生物学 微生物学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 甲基甲基酸 (MEP) 途径对于菌根菌的生存至关重要,合成重要的代谢物,如异oprenoids.
- 在MEP途径中的酶是开发新型抗结核药物的有吸引力的目标.
研究的目的:
- 研究Mycobacterium smegmatis中关键MEP通路基因 (DXS,IspD,IspF) 的下调的影响.
- 了解由此产生的对细菌活力,药物易感性,细胞壁完整性和基因表达的影响.
主要方法:
- 克里斯普尔干扰 (克里斯普尔i) 用于条件基因敲除.
- 转录学和定量实时PCR (qRT-PCR) 用于基因表达分析.
- 乙化 (EtBr) 积累测试用于评估细胞壁的透性.
主要成果:
- 低调DXS,IspD或IspF导致显著的杀菌效应和改变殖民地形态.
- 淘汰菌株对现有的抗结核药物敏感性增加.
- 减少EtBr积累表明细胞壁拓的改变.
- 转录分析显示了核糖体蛋白质,蛋白质转位,转录调节剂和代谢酶的显著变化.
结论:
- 准重要的MEP通路基因严重影响菌根菌的生长和功能.
- 抑制MEP通路可以提高当前抗结核疗法的疗效.
- 这项研究提供了关于神经菌在代谢压力下复杂的调节网络和生存策略的见解.
相关概念视频
Antibiotic Selection
48.9K
Overview
48.9K
Gene Regulation in Microbial Communities: Quorum Sensing
954
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
954
Development of Antibiotic Resistance
2.0K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Mechanism of Antibiotic Resistance in MRSA
219
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Inhibitors of Gram-positive Cell Wall Synthesis
191
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
191
Clinical Significance of Antibiotic Resistance
90
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90


